drugset / Trial / NCT01002495
Gene Therapy for the Treatment of Chronic Stable Angina
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of catheter based injections of VM202 into the heart.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-07
- Completion
- 2016-01
Outcome
Outcome not reported
Stopped: “The study was never initiated at any sites.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VM202 | Other / unclassified | 1 mg | Other |
| Subject | VM202 | Other / unclassified | 2 mg | Other |
| Subject | VM202 | Other / unclassified | 3 mg | Other |